Interesting article on likelihood to stay on treatment plan

I get it. Sticking to a medication plan for MS can be a challenge. You might feel a bit tied down by the injections or the IV treatment plans. Furthermore, the costs for such DMT are very steep – from $3000 to $9000 without insurance or support from the drug companies.

I wonder if insurance companies will begin to use AI software to see if a patient has the stick-to-it-ness prior to allowing the ordering of DMT, which come from specialty pharmacies.

This article is just the beginning of predicting patient behavior. We need to keep our eyes on this new type of tool as we walk through an ever-changing MS landscape.